Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,44655,1815,2.24 [1.92-2.61],4.381310565240713e-25
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,43928,434,3.77 [2.82-5.03],1.9629431357734785e-19
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,33738,1590,2.71 [2.29-3.20],2.314437951340605e-31
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",48913,834,2.22 [1.79-2.75],4.862718491670977e-13
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,45854,1597,2.97 [2.53-3.49],2.33252500420416e-40
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,49016,396,3.06 [2.25-4.16],8.781469870909301e-13
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,48368,710,2.52 [1.99-3.19],1.8219421771285668e-14
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,48368,710,2.52 [1.99-3.19],1.8219421771285668e-14
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),44569,934,2.10 [1.70-2.59],3.763282132511458e-12
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41683,2365,1.82 [1.58-2.09],3.561050690841913e-17
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,48572,1083,1.89 [1.54-2.31],5.466567783669564e-10
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46964,243,3.35 [2.28-4.92],7.498532976991401e-10
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,47835,1114,3.47 [2.88-4.20],3.8119004911122523e-38
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,47800,1079,3.39 [2.80-4.11],9.679993716398362e-36
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,41330,2012,1.65 [1.42-1.91],9.417545406738466e-11
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,41173,1855,1.67 [1.42-1.95],1.6475244296764788e-10
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Any mental disorder,43662,1304,2.83 [2.38-3.37],1.9309695336525708e-31
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",42814,456,4.54 [3.44-5.98],5.4119119466672e-27
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",50836,342,4.19 [3.09-5.67],2.4573109184378023e-20
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",50965,248,5.02 [3.55-7.11],8.653723186338102e-20
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Alcohol dependence,48104,142,7.63 [4.95-11.75],3.479452825485314e-20
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",43010,652,2.63 [2.06-3.35],1.0487794951763881e-14
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Depression,48428,572,2.38 [1.84-3.08],3.125478591915696e-11
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Depression or dysthymia,42494,498,2.72 [2.06-3.60],1.4750711215227138e-12
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Neurological diseases,44142,2967,1.68 [1.49-1.90],7.832675902136008e-17
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Epilepsy,48285,305,2.90 [2.07-4.07],7.15874684712538e-10
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,36530,6581,1.85 [1.68-2.05],1.5703251549733282e-33
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, essential",38463,4541,1.90 [1.70-2.13],2.9554510500621655e-29
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertension,38528,4606,1.87 [1.67-2.09],2.98936432184461e-28
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,41157,4132,1.88 [1.69-2.09],6.6690564626368414e-31
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,46123,2025,1.78 [1.54-2.06],6.3051036423125465e-15
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",49307,403,2.60 [1.93-3.51],2.94375804400061e-10
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",49307,403,2.60 [1.93-3.51],2.94375804400061e-10
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Asthma,36838,1673,1.75 [1.48-2.06],3.6986293938457225e-11
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",36298,1673,1.77 [1.50-2.09],1.0531794023685927e-11
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",36814,1649,1.77 [1.50-2.09],1.5242091675912435e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,35102,11695,1.81 [1.67-1.95],2.684341817388682e-50
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",43020,4325,1.88 [1.69-2.09],3.217453666571049e-32
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophagitis,39370,675,2.31 [1.81-2.95],1.5676266506176795e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,40085,1390,1.76 [1.48-2.10],3.583191672929742e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),40331,1636,2.22 [1.89-2.60],1.5746860768178274e-22
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,43645,1728,1.98 [1.70-2.32],6.641303181233466e-18
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,49675,1532,1.99 [1.69-2.35],1.5590179530801742e-16
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestines,40394,4028,1.60 [1.44-1.79],1.6667065080621868e-17
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,49383,1240,2.09 [1.74-2.50],1.314583744143483e-15
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49369,1226,2.04 [1.70-2.45],1.586739997896995e-14
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,36940,574,2.31 [1.77-3.00],6.303505243159936e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of liver,49994,250,9.26 [6.68-12.83],1.053971708937931e-40
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of liver,49882,138,6.50 [4.10-10.30],1.6589233971713337e-15
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",48875,1264,2.08 [1.73-2.49],2.869129375894148e-15
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of the digestive system,48837,628,2.44 [1.91-3.11],7.205749000695563e-13
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37145,7993,1.48 [1.36-1.62],1.6006703951393525e-19
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,46537,2419,1.57 [1.38-1.80],2.9926429220664303e-11
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36062,303,4.62 [3.29-6.50],1.5598786632890917e-18
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,36702,943,2.46 [2.00-3.02],1.814618061075492e-17
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",50781,291,4.12 [2.94-5.78],2.031962820081156e-16
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,50803,263,4.51 [3.18-6.40],2.9867259838859345e-17
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50510,261,4.46 [3.09-6.44],1.3076762186884157e-15
